![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.thepharmaletter.com/article/recordati-records-another-strong-performance-in-first-quarter
https://www.reuters.com/business/healthcare-pharmaceuticals/italys-recordati-nudges-up-2023-guidance-9-mth-revenue-profit-jumps-2023-11-07/
https://www.reuters.com/business/healthcare-pharmaceuticals/recordati-shares-fall-after-core-profit-margin-forecasts-disappoint-2023-02-21/
https://endpts.com/recordati-acquires-eusa-pharma-and-its-4-rare-disease-drugs-but-analysts-question-strategy-behind-the-deal/
https://pharmaphorum.com/news/alnylam-gets-nice-backing-for-porphyria-therapy-givlaari/